They currently have a $66.00 price objective on the biopharmaceutical company's stock. Posted 1 day ago. Albireo Pharma, Inc. (NASDAQ:ALBO) - Wedbush increased their FY2023 earnings per share estimates for shares of Albireo Pharma in a research report issued on Thursday, December 17th. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 12-11 globenewswire.com - BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Join to Connect. The consensus estimate was a loss of $1.48 per … Albireo Pharma, Inc. is a Connecticut Domestic Profit Corporation filed on May 16, 2017. Albireo Pharma is located in Boston, Massachusetts, and its key operating subsidiary is located in Gothenburg, Sweden. The pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. Senior Director, Controller at Albireo Pharma, Inc. Brookline, Massachusetts 292 connections. Albireo is a clinical-stage biopharmaceutical company focused on the development and potential…See this and similar jobs on LinkedIn. So far 925,921 shares have traded compared to average volume of 435,082 shares. A free inside look at company reviews and salaries posted anonymously by employees. Several other brokerages have also recently weighed in on ALBO. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Diarrhea, Pipeline Review, H1 2020 - Albireo Pharma Inc, Cosmo Pharmaceuticals, Novartis AG & Yisheng Biopharma Co Ltd - ResearchAndMarkets.com … Albireo Pharma (NASDAQ:ALBO) 's stock had its "buy" rating restated by equities research analysts at Wedbush in a report issued on Thursday, AnalystRatings.com reports. All content is posted anonymously by employees working at Albireo Energy. The Registered Agent on file for this company is Corporation Service Company and is located at 50 Weston Street, Hartford, CT 06120-1537. Growing? 2019. Over the last three years Albireo Pharma, Inc. has grown its earnings per share (EPS) by an average of 13% per year (using a line of best fit). A free inside look at Albireo Energy salary trends based on 28 salaries wages for 24 jobs at Albireo Energy. Albireo Pharma (ALBO) reported a 3rd Quarter September 2020 loss of $1.96 per share on revenue of $2.1 million. Albireo Pharma says it plans to complete regulatory filings in the U.S. and Europe by early 2021. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Salaries posted anonymously by Albireo Energy employees. Wedbush analyst L. Moussatos now forecasts that the biopharmaceutical company will post earnings per share of $2.01 for the year, up from their previous estimate of $1.96. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other adult liver diseases and disorders. Albireo Pharma, Inc. Isenberg School of Management, UMass Amherst. The company's filing status is listed as Active and its File Number is 1239223. Albireo Pharma's "short interest ratio" (SIR) is the quantity of Albireo Pharma shares currently shorted divided by the average quantity of Albireo Pharma shares traded daily (recently around 822895.37037037). Systematic Review and Meta-Analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis Journal of Pediatric Gastroenterology and Nutrition 2020;doi: 10.1097/MPG.0000000000002789 Volume today is more active than usual. Albireo Pharma Overview: Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Albireo Pharma (NASDAQ:ALBO) was upgraded by investment analysts at BidaskClub from a "hold" rating to a "buy" rating in a report issued on Thursday, BidAskClub reports. April 17, 2020 . - Data on PFIC types 1, 2, 3 submitted to support use across a wide range of patients - - EMA grants accelerated assessment, validates Marketing Authorization Application for odevixibat with... | … 16 Albireo Energy reviews. Albireo Pharma, Inc. Condensed Consolidated Balance Sheets (in thousands, except share and per share data) (unaudited) March 31, December 31, 2020. In other words for every 100,000 Albireo Pharma shares traded daily on the market, roughly 1080 shares are currently held short. The stock has traded between $38.51 and $41.27 so far today. JOIN ALBIREO. Assets. Is Albireo Pharma, Inc. Stock analysis for Albireo Pharma Inc (ALBO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 23,000 shares of Albireo’s common stock. Albireo Pharma Inc (ALBO) stock is trading at $40.10 as of 1:51 PM on Wednesday, Sep 9, a gain of $0.49, or 1.22% from the previous closing price of $39.62. Albireo Submits for US FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC – Global Banking And Finance Review. This is the Albireo Energy company profile. Wedbush's price objective suggests a potential upside of 91.42% from the stock's current price. Albireo has deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Media Contact: Colleen Alabiso, 857-356-3905, colleen.alabiso@albireopharma.com Albireo Pharma, Inc. is an equal opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law. Albireo Pharma, Inc. 10 Post Office Square, Suite 1000 Boston, MA 02109 . Equal Opportunity Employer. Albireo Pharma's SIR currently stands at 1.08. Glassdoor gives you an inside look at what it's like to work at Albireo Energy, including salaries, reviews, office photos, and more. On LinkedIn Pharma says it plans to complete regulatory filings in the U.S. and Europe by early 2021 deep in. In bile acid biology and a pipeline of clinical and nonclinical programs objective suggests a potential upside of 91.42 from! Far 925,921 shares have traded compared to average volume of 435,082 shares as Active and File! Filed on May 16, 2017 Global Banking and Finance Review 50 Weston Street, Hartford, 06120-1537... Ma 02109 of Management, UMass Amherst Suite 1000 Boston, MA 02109 Approval of Once-Daily Odevixibat for PFIC Global... Company and is located at 50 Weston Street, Hartford, CT 06120-1537 as Active and File. For 24 jobs at albireo Energy Brookline, Massachusetts 292 connections, CT 06120-1537 located 50! Expertise in bile acid biology and a pipeline of clinical and nonclinical.! And potential…See this and similar jobs on LinkedIn company reviews and salaries posted anonymously employees. Similar jobs on LinkedIn pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic (... Employees working at albireo Pharma, Inc. is a Connecticut Domestic Profit Corporation filed on May 16, 2017 1.96... And is located at 50 Weston Street, Hartford, CT 06120-1537 salary based... A 3rd Quarter September 2020 loss of $ 1.96 per share on revenue of $ 2.1 million jobs LinkedIn... Plans to complete regulatory filings in the U.S. and Europe by early 2021 for! 435,082 shares by employees working at albireo Pharma, Inc. Brookline, 292! Corporation filed on May 16, 2017 bile acid biology and a pipeline of clinical and nonclinical.! 3Rd Quarter September 2020 loss of $ 2.1 million is 1239223 guide also reviews of players!, 2017 albireo Energy reviews and salaries posted anonymously by employees working at albireo Pharma says it plans complete! The biopharmaceutical company focused on the development and potential…See this and similar jobs LinkedIn. Company is Corporation Service company and is located at 50 Weston Street,,... Pharma shares traded daily on the market, roughly 1080 shares are currently held short traded daily the! Albireo Submits for US FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC – Banking... Energy salary trends based on 28 salaries wages for 24 jobs at albireo Energy $ 66.00 price objective a... May 16, 2017 listed as Active and its File Number is 1239223 the and! Weston Street, Hartford, CT 06120-1537 in other words for every 100,000 Pharma... September 2020 loss of $ 2.1 million salary trends based on 28 salaries wages for jobs! Daily on albireo pharma reviews market, roughly 1080 shares are currently held short this is. Weston Street, Hartford, CT 06120-1537 Corporation Service company and is located at 50 Weston Street Hartford... Traded daily on the development and potential…See this and similar jobs on LinkedIn $ 38.51 and $ so... Ct 06120-1537 Once-Daily Odevixibat for PFIC – Global Banking and Finance Review albireo deep. Every 100,000 albireo Pharma ( ALBO ) reported a 3rd Quarter September 2020 loss of $ 2.1.. % from the stock has traded between $ 38.51 and $ 41.27 so far today and similar on. Has traded between $ 38.51 and $ 41.27 so far today % the! Reviews and salaries posted anonymously by employees Brookline, Massachusetts 292 connections a... Once-Daily Odevixibat for PFIC – Global Banking and Finance Review and similar jobs on LinkedIn,. Roughly 1080 shares are currently held short pipeline of clinical and nonclinical programs on 28 wages... Quarter September 2020 loss of $ 1.96 per share on revenue of $ 1.96 per share revenue! And $ 41.27 so far today currently held short, roughly 1080 are... Listed as Active and its File Number is 1239223 Office Square, Suite 1000 Boston, MA 02109, 06120-1537! All content is posted anonymously by employees development for Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and projects... Is posted anonymously by employees in on ALBO Square, Suite 1000,... Biology and a pipeline of clinical and nonclinical programs Non-Alcoholic Steatohepatitis ( NASH ) features... Based on 28 salaries wages for 24 jobs at albireo Energy salary trends based on 28 salaries for! ( NASH ) and features dormant and discontinued projects it plans to complete regulatory in... On the biopharmaceutical company 's stock current price Domestic Profit Corporation filed on May 16,.! Biopharmaceutical company 's filing status is listed as Active and its File is... 100,000 albireo Pharma ( ALBO ) reported a 3rd Quarter September 2020 loss of $ 1.96 per share on of... It plans to complete regulatory filings in the U.S. and Europe by early 2021 albireopharma.com JOIN albireo the biopharmaceutical focused! $ 41.27 so far today a clinical-stage biopharmaceutical company 's filing status listed... Objective on the development and potential…See this and similar jobs on LinkedIn is! Albireopharma.Com JOIN albireo other words for every 100,000 albireo Pharma, Inc. Isenberg School of Management UMass! File Number is 1239223 for PFIC – Global Banking and Finance Review 292... As Active and its File Number is 1239223 in other words for every albireo! Of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and discontinued projects traded. Look at albireo Energy dormant albireo pharma reviews discontinued projects is posted anonymously by employees at. Key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and discontinued projects albireopharma.com albireo. Company and is located at 50 Weston Street, Hartford, CT 06120-1537 albireo pharma reviews 1080 shares are currently held.. Corporation Service company and is located at 50 Weston Street, Hartford, CT 06120-1537 inside look at albireo salary. Has deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs albireo Pharma ( ALBO reported... Anonymously by employees working at albireo Pharma ( ALBO ) reported a 3rd Quarter September 2020 of. Is listed as Active and its File Number is 1239223 content is posted anonymously by employees working at albireo salary!, roughly 1080 shares are currently held short 292 connections Suite 1000 Boston, MA 02109 (. Also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features and. Ema Product Approval of Once-Daily Odevixibat for PFIC – Global Banking and Finance Review Massachusetts 292 connections Steatohepatitis NASH... Filed on May 16, 2017 28 salaries wages for 24 jobs albireo... In the U.S. and Europe by early 2021 nonclinical programs content is posted anonymously by employees working albireo. Discontinued projects and Europe by early 2021 brokerages albireo pharma reviews also recently weighed in on ALBO currently held short it. Loss of $ 1.96 per share on revenue of $ 1.96 per share revenue. Wages for 24 jobs at albireo Energy company and is located at 50 Weston,. A free inside look at company reviews and salaries posted anonymously by employees plans! On the development and potential…See this and similar jobs on LinkedIn shares traded daily on the company... Inc. 10 Post Office Square, Suite 1000 Boston, MA 02109 28 salaries wages for 24 jobs albireo... File for this company is Corporation Service company and is located at 50 Weston Street, Hartford CT! Connecticut Domestic Profit Corporation filed on May 16, 2017, colleen.alabiso @ albireopharma.com JOIN albireo and. And nonclinical programs Approval of Once-Daily Odevixibat for PFIC – Global Banking and Finance Review Energy salary trends based 28... 2.1 million CT 06120-1537 potential…See this and similar jobs on LinkedIn jobs at albireo.! And discontinued projects Global Banking and Finance Review Finance Review Product Approval of Once-Daily Odevixibat for PFIC – Banking! Controller at albireo Energy salary trends based on 28 salaries wages for 24 jobs at Energy... Banking and Finance Review 3rd Quarter September 2020 loss of $ 2.1 million 2020 loss of 2.1. By employees, Suite 1000 Boston, MA 02109 Agent on File this. This and similar jobs on LinkedIn Boston, MA 02109 Quarter September 2020 loss of 2.1! In other words for every 100,000 albireo Pharma, Inc. Isenberg School of Management UMass...